EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Germline Susceptibility to Therapeutic Vulnerability: DNA Damage Response Gene Mutations Driving Multiple Myeloma Evolution and Precision Therapy

Qian Shen iD, Ying Wang iD, Liuhuan Cai iD, Juan Qian iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/7757115 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Mutation, online erschienen am 17.06.2026. Verfasst von Qian Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Lymphoma, Tumor Hospital Affiliated to Nantong University, Nantong, China, ntzlyy.cn. Hauptthemen laut MEDLINE: Multiple Myeloma, Germ-Line Mutation, Precision Medicine, DNA Damage. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is characterized by genomic instability and therapeutic resistance. Emerging evidence indicates that germline DNA damage response (DDR) mutations, including BRCA1/2, ATM, and CHEK2 variants, contribute to MM susceptibility, clonal evolution, and treatment response. Inherited DDR defects promote chromosomal instability, reshape the immune microenvironment, and facilitate therapy‐driven disease progression. Recent advances in multiomics profiling, single‐cell sequencing, and liquid biopsy have improved the functional interpretation and clinical monitoring of DDR alterations. Moreover, DDR‐associated vulnerabilities provide opportunities for precision therapies, including PARP inhibitor–based synthetic lethality strategies. This review summarizes the mechanistic and clinical significance of germline DDR alterations in MM and highlights their translational potential in precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaGerm-Line MutationPrecision MedicineDNA DamageGenetic Predisposition to DiseaseHumansGenomic InstabilityDNA RepairCheckpoint Kinase 2Ataxia Telangiectasia Mutated ProteinsBRCA1 Protein

Stichwörter der Autor:innen

DNA damage responsegene mutationgenomic instabilitygermline mutationmultiple myelomaprecision medicine

Substanzen

Checkpoint Kinase 2Ataxia Telangiectasia Mutated ProteinsBRCA1 Protein

Autor:innen und Institutionen

  • Department of Hematology and Lymphoma, Tumor Hospital Affiliated to Nantong University, Nantong, China, ntzlyy.cn.

ORCID-Profile: Qian Shen, Ying Wang, Liuhuan Cai, Juan Qian

Zitieren

APA

Shen, Q., Wang, Y., Cai, L., & Qian, J. (2026). From Germline Susceptibility to Therapeutic Vulnerability: DNA Damage Response Gene Mutations Driving Multiple Myeloma Evolution and Precision Therapy. Human Mutation, 2026(1). https://doi.org/10.1155/humu/7757115

Vancouver

Shen Q, Wang Y, Cai L, Qian J. From Germline Susceptibility to Therapeutic Vulnerability: DNA Damage Response Gene Mutations Driving Multiple Myeloma Evolution and Precision Therapy. Human Mutation. 2026;2026(1). doi:10.1155/humu/7757115

BibTeX
@article{Shen2026,
  author = {Shen, Qian and Wang, Ying and Cai, Liuhuan and Qian, Juan},
  title = {From Germline Susceptibility to Therapeutic Vulnerability: DNA Damage Response Gene Mutations Driving Multiple Myeloma Evolution and Precision Therapy},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/7757115}
}
Kostenlos starten →